Splenic lymphoma with villous lymphocytes (SLVL)

Troussard, Xavier; Mossafa, Hossain

doi:10.4267/2042/38190

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical features include massive splenomegaly and absence of peripheral lymphadenopathy. In our patient, an incidental finding of splenomegaly led to her having a splenectomy for SLVL [7]. …”

Section: Discussionmentioning

confidence: 99%

Mantle cell lymphoma presenting as a pelvi-ureteric junction obstruction: a case report

2013

View full text Add to dashboard Cite

IntroductionMantle cell lymphoma is one of the several subtypes of non-Hodgkin’s lymphoma. Mantle cell lymphoma is the rarest of the subtypes, accounting for about 6% of all non-Hodgkin’s lymphoma cases in the United States and Europe. Lymphoid neoplasms of the urinary tract and male genital organs are relatively rare, accounting for less than 5% of extranodal lymphomas. We present a rare case of mantle cell lymphoma infiltrating the ureter causing pelvi-ureteric junction obstruction on tissue diagnosis.Case presentationA 78-year-old Caucasian woman was referred to our department with right flank pain, pyrexia and features of a urinary tract infection. A nephrostogram revealed a grossly distended right pelvicalyceal system in a pelvi-ureteric junction obstruction pattern. She underwent an elective pyeloplasty after her acute management and the results of histological examination revealed mantle cell lymphoma.ConclusionWe describe a rare presentation of mantle cell lymphoma as a pelvi-ureteric junction obstruction. To the best of our knowledge, there has not been any previously published report of the above finding. Our patient had a history of a previous lymphoma but the aim of this manuscript is to highlight a possible presentation rather than determining whether the mantle cell lymphoma was de novo or a transformation from her previous splenic lymphoma with villous lymphocytes.

show abstract

Section: Discussionmentioning

confidence: 99%